Scott Whitaker, President and CEO of AdvaMed, The Medtech Association®, released the following statement regarding the bipartisan “Roadmap for Artificial Intelligence Policy in the U.S. Senate” released yesterday by Senate Majority Leader Chuck…
Today, AdvaMed, The Medtech Association®, and Consumer Technology Association (CTA)® hosted a Congressional Digital Health Caucus briefing on remote patient monitoring (RPM) in coordination with Caucus co-chairs Rep. Troy Balderson…
This week, AdvaMed, The Medtech Association®, responded to a request for information from Congressman Ami Bera regarding the use of artificial intelligence (AI) in health care.
Today, AdvaMed, The Medtech Association®, released the following statements from President and CEO Scott Whitaker and Zach Rothstein, Executive Director of AdvaMedDx®, on FDA’s final rule for Laboratory Developed Tests (LDTs):
The newest episode of Medtech POV with Scott Whitaker, out today on all podcast streaming platforms, highlights Venk Varadan’s journey as a medtech entrepreneur. Varadan, CEO and co-founder of Nanowear,…
This week, in a letter to Senate Majority Leader Chuck Schumer, AdvaMed® President and CEO Scott Whitaker underscored the critical importance of passing a tax provision that allows small businesses…
AdvaMed, The Medtech Association®, released the following statement thanking the FDA Center for Radiological Health (CDRH) for recently hosting an event in New Delhi to discuss regulatory policies and best practices for ensuring…
AdvaMed, The Medtech Association®, unveiled a timer on the organization’s website to track the number of days since the Centers for Medicare and Medicaid Services (CMS) ended the coverage pathway…
Today, Zach Rothstein, Executive Director of AdvaMedDx®, testified before the House Energy and Commerce Committee, Subcommittee on Health during a hearing on diagnostic test regulation and FDA’s proposed laboratory developed…
Today, AdvaMed, The Medtech Association®, announced Board Chairman Peter Arduini’s priorities to guide the vision of the medtech industry over the course of his two-year term. The priorities, which are…